Generated by GPT-5-mini| Journal of Biomedical Materials Research | |
|---|---|
| Title | Journal of Biomedical Materials Research |
| Discipline | Biomaterials, Biomedicine |
| Abbreviation | J. Biomed. Mater. Res. |
| Publisher | Wiley |
| Country | United States |
| History | 1967–present |
| Frequency | Monthly |
| Impact | 3.5 |
| Issn | 0021-9304 |
Journal of Biomedical Materials Research is a peer-reviewed scientific periodical addressing biomaterials research and applications in medicine and biology. It publishes original research, reviews, and technical reports on synthetic and natural materials used in implants, prostheses, tissue engineering, and drug delivery. The journal serves researchers in academic institutions, industrial laboratories, and clinical centers.
The journal was established in 1967 during a period of rapid development in biomedical engineering, contemporaneous with institutions such as Massachusetts Institute of Technology, Johns Hopkins University, University of California, San Francisco, Stanford University, and University of Pennsylvania expanding materials programs. Early contributors included investigators affiliated with National Institutes of Health, Food and Drug Administration, Wyss Institute at Harvard University, and national laboratories like Argonne National Laboratory and Oak Ridge National Laboratory. Over successive editorial tenures the title evolved alongside milestones such as the development of polymethyl methacrylate bone cement, the introduction of silicone prostheses, the rise of biodegradable polymers at centers like University of Massachusetts Amherst and Drexel University, and regulatory frameworks influenced by rulings from United States Court of Appeals and guidance from European Medicines Agency. The journal later paralleled the emergence of specialized journals from publishers including Elsevier, Springer Nature, and Wiley-Blackwell.
The journal covers experimental and translational studies spanning biomaterials synthesis and characterization, biocompatibility testing, surface modification, in vitro and in vivo evaluation, and clinical translation. Topics include metallic implants investigated at facilities such as Cleveland Clinic, ceramic research from groups at Imperial College London, polymer science linked to work at Massachusetts Institute of Technology, hydrogel systems explored by researchers at California Institute of Technology, and composite scaffolds developed through collaborations with National Institute of Standards and Technology. The focus extends to interdisciplinary intersections with groups at Harvard Medical School, University of Michigan, Columbia University, University of Toronto, and ETH Zurich examining tissue engineering strategies, nanomaterial interfaces, and controlled release platforms informed by studies associated with National Institutes of Health, Wellcome Trust, National Science Foundation, and European Research Council grants.
Published by Wiley on a monthly schedule, the journal is managed by an editorial board composed of researchers from institutions such as University of Minnesota, University College London, University of Sydney, Seoul National University, and Peking University. Editors coordinate peer review with reviewers drawn from societies including the Society For Biomaterials, Biomedical Engineering Society, and regional organizations like European Society for Biomaterials and Japanese Society for Biomaterials. Manuscript submission procedures align with guidelines advocated by Committee on Publication Ethics and indexing practices observed by publishers like Taylor & Francis and SAGE Publications. Special issues have been guest-edited by scholars associated with Rockefeller University, Karolinska Institutet, and University of Tokyo.
The journal is abstracted and indexed in major databases and services such as PubMed, MEDLINE, Scopus, Web of Science, and Embase. Library holdings include cataloging through systems used by Library of Congress, British Library, and National Library of Medicine. Citation tracking is available via platforms like Google Scholar and CrossRef, with digital object identifiers assigned through CrossRef and archival preservation coordinated with initiatives similar to Portico and LOCKSS.
The journal has influenced clinical implants and regulatory standards referenced in white papers from bodies such as Food and Drug Administration, European Medicines Agency, and consensus statements from professional groups like the American Academy of Orthopaedic Surgeons and the International Society for Technology in Arthroplasty. Its articles have been cited in guideline documents from World Health Organization committees, systematic reviews produced by teams at Cochrane Collaboration, and technology roadmaps by agencies including National Institutes of Health and Defense Advanced Research Projects Agency. Reception among academic departments at University of Oxford, Princeton University, Yale University, and Cornell University views the journal as a venue for applied biomaterials research with translational impact.
Notable contributions include early reports on biocompatibility testing methodologies referenced alongside studies from National Institutes of Health laboratories, landmark papers on biodegradable polymer degradation kinetics used by researchers at Massachusetts Institute of Technology and Duke University, and influential reviews on surface modification techniques cited by teams at Imperial College London and ETH Zurich. Other widely cited articles addressed topics such as hydrogel scaffold design with relevance to work at Karolinska Institutet and University of Toronto, nanocomposite prostheses informed by collaborations with Fraunhofer Society researchers, and controlled drug-release matrices applied in clinical trials at Mayo Clinic and Cleveland Clinic.
Category:Biomedical journals Category:Wiley academic journals